Search Results - therapeutics

3 Results

Sort By:

Mitochondrial-Targeted Peptide Modulators of Delta Protein Kinase C Interaction with the d-subunit of F1Fo ATP Synthase/ATPase as Therapeutics Against Cardiac Injury

Current State of the Art: Current clinical therapy for heart attack victims focuses on the rapid restoration of blood flow by thrombolysis, angioplasty, stenting and when appropriate surgical coronary artery bypass grafts. Problems with the Current Art: The majority of cardiac cell death associated with a heart attack actually occurs during the...

Published: 4/29/2020 | Inventor(s): John Johnson, Tiffany Tuyen Nguyen, Mourad Ogbi

Keywords(s): Cardiovascular, Heart Attack, Therapeutics

Category(s): Therapeutics

Gene for Successful Aging Without Cognitive Decline

Title: Biomarker for Successful Aging without Cognitive Decline Current State of the Art: It is estimated that up to one third of adults will experience a gradual decline in cognitive function known as mild cognitive impairment as they age. Individuals with cognitive decline are able to function reasonably well in everyday activities, such as managing...

Published: 6/21/2021 | Inventor(s): Shirley Poduslo

Keywords(s): Aging, Alzheimer's Disease, Therapeutics

Category(s): Diagnostics

Development of Novel Therapies for Experimental Guillain-Barre Syndrome Using Ganglioside-Like Phage-Peptide

Current State of the Art:Guillain Barre syndrome is currently treated by administering pain relievers and other palliative forms of care to reduce the symptoms associated with the disease. Guillain Barre currently affects about 1 out of 50,000 people world-wide and in some instances has proven to be fatal due to limited treatments readily available...

Published: 4/28/2020 | Inventor(s): Robert Yu, Seigo Usuki

Keywords(s): Guillain-Barre, Phage-Peptide, Therapeutics

Category(s): Therapeutics